We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Lack of FDA Guidance Is Barrier to Promising mHealth App Market

Lack of FDA Guidance Is Barrier to Promising mHealth App Market

August 22, 2013
By the end of 2017, revenues from mHealth products will rise by 61 percent to $26 billion, according to a new analysis by Research2Guidance. But lack of final FDA guidance on mHealth apps is keeping devicemakers from realizing the full potential of this segment, the report says. App publishers surveyed for the report listed “missing regulations” as the main market barrier.
Devices & Diagnostics Letter

Upcoming Events

  • 15Jun

    Recall Readiness: Dust Off Your SOPs, There’s a New Guidance in Town

  • 21Jun

    Medical Device Reporting: Best Practices and Common Pitfalls

  • 22Jun

    Meet CDRH’s New Strategic Priorities: Where the Center is Headed and How Devicemakers Can Keep Up

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Hologic Gets CE Marks for Molecular Assays for Transplant Patients

  • DePuy Synthes’s Inhance Shoulder System Gains New Clearance

  • United Therapeutics’ Tyvaso DPI Approved for Rare High Blood Pressure Disease

  • FDA Grants Fast-Track Label to Pfizer’s Combination Therapy for NASH

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing